Lower p66Shc promoter methylation in subjects with chronic renal failure

• Published in: PloS one Vol. 16; no. 9; p. e0257176
• Main Authors: Hamdi, Radhia, Saadallah-Kallel, Amana, Ferchichi-Trimeche, Slima, Mokdad-Gargouri, Raja, Miled, Abdelhedi, Benarba, Bachir
• Format: Journal Article
• Language: English
• Published: San Francisco Public Library of Science 16.09.2021; Public Library of Science (PLoS)
• Subjects: Apoptosis; Biochemistry; Biology and life sciences; Biotechnology; Chronic kidney failure; Correlation; Creatinine; Deoxyribonucleic acid; Development and progression; Diabetes; Disease; DNA; DNA methylation; Environmental aspects; Epigenetics; Genetic aspects; Health care; Hepatitis; HIV; Human immunodeficiency virus; Kinases; Laboratories; Markers; Medicine and Health Sciences; Methods; Methylation; Molecular biology; Multiple regression analysis; Nephrology; Oxidative stress; Patients; Pharmacy; Physical Sciences; Proteins; Regression analysis; Renal failure; Urea; Uric acid; Tunisia
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0257176

Objective To determine the correlation between DNA methylation of p66Shc promoter and some markers of inflammatory and oxidative stress in chronic renal failure (CRF) patients compared with healthy subjects. Methods An observational cross-sectional study was conducted in the nephrology department at Sidi Bouzid Regional Hospital (Tunisia). In total, 39 patients with CRF and 37 healthy subjects were included. Several biochemical parameters were measured. Furthermore, markers of the oxidative and inflammatory status (MDA, TAS, SOD, and CRP) were evaluated. The p66Shc methylation status was determined using the methylation-specific PCR. Results Our results showed that levels of blood glucose, urea, creatinine, uric acid, ChT, TG, albuminuria, CRP and MDA were significantly elevated in CRF patients compared to controls. Furthermore, p66Shc promoter region was highly demethylated in CRF patients compared to healthy controls (84% vs 4%). Our data showed a positive correlation between p66Shc hypomethylation and levels of MDA (r = 0.93; p<0, 05) and CRP (r = 0.89; P <0, 05), as well as a significant negative correlation between p66Shc hypomethylation, TAS (r = -0.76; P <0, 05) and SOD (r = -0.77; p<0, 05) levels. Similarly, there was a positive correlation between p66Shc hypomethylation and the disease stages. Importantly, multiple regression analysis showed that p66shc DNA hypomethylation remains strongly correlated with MDA, CRP and stages of CRF. Conclusion This study indicates that the DNA hypomethylation of p66shc promoter was correlated with oxidative and inflammatory stress and the disease stages in CRF patients.